{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:03:00Z","timestamp":1775142180418,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.bbrc.2009.10.031","type":"journal-article","created":{"date-parts":[[2009,10,14]],"date-time":"2009-10-14T14:14:00Z","timestamp":1255529640000},"page":"368-371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Targeting carbonic anhydrase to treat diabetic retinopathy: Emerging evidences and encouraging results"],"prefix":"10.1016","volume":"390","author":[{"given":"Zhang","family":"Weiwei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2009.10.031_bib1","unstructured":"IDF-Atlas, third ed., 2006."},{"issue":"Suppl. 1","key":"10.1016\/j.bbrc.2009.10.031_bib2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2337\/diacare.27.2007.S84","article-title":"American Diabetes Association, Retinopathy in diabetes","volume":"27","author":"Fong","year":"2004","journal-title":"Diabetes Care."},{"key":"10.1016\/j.bbrc.2009.10.031_bib3","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.eye.6701476","article-title":"Epidemiology of diabetic retinopathy and macular oedema: a systematic review","volume":"18","author":"Williams","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.bbrc.2009.10.031_bib4","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/jama.298.8.902","article-title":"Management of diabetic retinopathy: a systematic review","volume":"298","author":"Mohamed","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.bbrc.2009.10.031_bib5","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0161-6420(98)91020-X","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes","volume":"105","author":"Klein","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.bbrc.2009.10.031_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000098254","article-title":"Laser treatment in diabetic retinopathy","volume":"221","author":"Neubauer","year":"2007","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.bbrc.2009.10.031_bib7","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.ophtha.2006.07.032","article-title":"Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy","volume":"113","author":"Aiello","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.bbrc.2009.10.031_bib8","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/01.iae.0000247165.38655.bf","article-title":"Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema","volume":"26","author":"Haritoglou","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.bbrc.2009.10.031_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0002-9394(54)92027-9","article-title":"Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, diamox; a preliminary report","volume":"37","author":"Becker","year":"1954","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.bbrc.2009.10.031_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00417-003-0817-3","article-title":"Carbonic anhydrase inhibition increases retinal oxygen tension and dilates retinal vessels","volume":"243","author":"Pedersen","year":"2005","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.bbrc.2009.10.031_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1023\/A:1002143802926","article-title":"The role of carbonic anhydrase inhibitors in the management of macular edema","volume":"97","author":"Wolfensberger","year":"1999","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.bbrc.2009.10.031_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nm1534","article-title":"Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation","volume":"13","author":"Gao","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2009.10.031_bib13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2009.10.031_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.bi.64.070195.002111","article-title":"Human carbonic anhydrases and carbonic anhydrase deficiencies","volume":"64","author":"Sly","year":"1995","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbrc.2009.10.031_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/14756360410001689540","article-title":"Carbonic anhydrases: current state of the art, therapeutic applications and future prospects","volume":"19","author":"Pastorekova","year":"2004","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bbrc.2009.10.031_bib16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2174\/138161208783877866","article-title":"The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents","volume":"14","author":"Mincione","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbrc.2009.10.031_bib17","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1369\/jhc.4A6266.2004","article-title":"Carbonic anhydrase in mammalian vascular smooth muscle","volume":"52","author":"Berg","year":"2004","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bbrc.2009.10.031_bib18","first-page":"419","article-title":"Carbonic anhydrase isoenzymes CA I and CA II in the human eye","volume":"27","author":"Wistrand","year":"1986","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbrc.2009.10.031_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1748-1716.1981.tb06918.x","article-title":"The importance of carbonic anhydrase B and C for the unloading of CO2 by the human erythrocyte","volume":"113","author":"Wistrand","year":"1981","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.bbrc.2009.10.031_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(02)00438-6","article-title":"Acetazolamide: future perspective in topical glaucoma therapeutics","volume":"248","author":"Kaur","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbrc.2009.10.031_bib21","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1073\/pnas.88.7.2716","article-title":"Localization of carbonic anhydrase IV in a specific capillary bed of the human eye","volume":"88","author":"Hageman","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2009.10.031_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002329900339","article-title":"Cytoplasmic pH responses to carbonic anhydrase inhibitors in cultured rabbit nonpigmented ciliary epithelium","volume":"162","author":"Wu","year":"1998","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.bbrc.2009.10.031_bib23","doi-asserted-by":"crossref","first-page":"8030","DOI":"10.1073\/pnas.0503021102","article-title":"Carbonic anhydrase XIV is enriched in specific membrane domains of retinal pigment epithelium, Muller cells, and astrocytes","volume":"102","author":"Nagelhus","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2009.10.031_bib24","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archopht.1988.01060140350030","article-title":"Treatment of chronic macular edema with acetazolamide","volume":"106","author":"Cox","year":"1988","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.bbrc.2009.10.031_bib25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0014-4835(75)90223-7","article-title":"A possible vascular mechanism for the inhibition of aqueous humor formation by ouabain and acetazolamide","volume":"20","author":"Macri","year":"1975","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbrc.2009.10.031_bib26","first-page":"121","article-title":"Enhancement of retinal adhesion and subretinal fluid resorption by acetazolamide","volume":"23","author":"Marmor","year":"1982","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbrc.2009.10.031_bib27","first-page":"893","article-title":"The effect of metabolic inhibitors on retinal adhesion and subretinal fluid resorption","volume":"19","author":"Marmor","year":"1980","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbrc.2009.10.031_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s00417-002-0560-1","article-title":"Blockers of carbonic anhydrase can cause increase of retinal capillary diameter, decrease of extracellular and increase of intracellular pH in rat retinal organ culture","volume":"241","author":"Reber","year":"2003","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"10.1016\/j.bbrc.2009.10.031_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.exer.2003.11.010","article-title":"Dorzolamide induces vasodilatation in isolated pre-contracted bovine retinal arteries","volume":"78","author":"Josefsson","year":"2004","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbrc.2009.10.031_bib30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.bjp.0703825","article-title":"In vivo evidence for K(Ca) channel opening properties of acetazolamide in the human vasculature","volume":"132","author":"Pickkers","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2009.10.031_bib31","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1159\/000080942","article-title":"Retinal peripapillary blood flow before and after topical brinzolamide","volume":"218","author":"Iester","year":"2004","journal-title":"Ophthalmologica"},{"issue":"Suppl. 2","key":"10.1016\/j.bbrc.2009.10.031_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0039-6257(99)00124-1","article-title":"Increased optic nerve head blood flow after 1 week of twice daily topical brinzolamide treatment in Dutch-belted rabbits","volume":"44","author":"Barnes","year":"2000","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.bbrc.2009.10.031_bib33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.survophthal.2008.06.002","article-title":"Literature review and meta-analysis of topical carbonic anhydrase inhibitors and ocular blood flow","volume":"54","author":"Siesky","year":"2009","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.bbrc.2009.10.031_bib34","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0042-6989(98)00004-2","article-title":"Does dark adaptation exacerbate diabetic retinopathy? Evidence and a linking hypothesis","volume":"38","author":"Arden","year":"1998","journal-title":"Vision Res."},{"key":"10.1016\/j.bbrc.2009.10.031_bib35","first-page":"1512","article-title":"Conjunctival hypoxia in diabetes mellitus","volume":"27","author":"Isenberg","year":"1986","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbrc.2009.10.031_bib36","first-page":"2756","article-title":"Optic nerve oxygen tension in pigs and the effect of carbonic anhydrase inhibitors","volume":"40","author":"Stef\u00e1nsson","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbrc.2009.10.031_bib37","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1167\/iovs.07-0508","article-title":"Dorzolamide increases retinal oxygen tension after branch retinal vein occlusion","volume":"49","author":"Noergaard","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbrc.2009.10.031_bib38","series-title":"The Retinal Pigment Epithelium","first-page":"226","article-title":"Adhesive forces between the retinal pigment epithelium and sensory retina","author":"Zauberman","year":"1979"},{"key":"10.1016\/j.bbrc.2009.10.031_bib39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s004170050013","article-title":"Inhibition of membrane-bound carbonic anhydrase enhances subretinal fluid absorption and retinal adhesiveness","volume":"238","author":"Wolfensberger","year":"2000","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.bbrc.2009.10.031_bib40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-0038-1657336","article-title":"Platelets, coagulation and fibrinolysis in patients with diabetic retinopathy","volume":"49","author":"Brooks","year":"1983","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bbrc.2009.10.031_bib41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1749-6632.1984.tb12334.x","article-title":"Carbonic anhydrase in human platelets: effects of carbonic anhydrase inhibition on platelet aggregation","volume":"429","author":"Siffert","year":"1984","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.bbrc.2009.10.031_bib42","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1042\/bj2170727","article-title":"Carbonic anhydrase in human platelets","volume":"217","author":"Siffert","year":"1984","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2009.10.031_bib43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1023\/A:1008986329267","article-title":"Sodium\u2013hydrogen exchange and platelet function","volume":"8","author":"Rosskopf","year":"1999","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.bbrc.2009.10.031_bib44","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0006-291X(84)90717-4","article-title":"The effect of carbonic anhydrase inhibition on the velocity of thrombin-stimulated platelet aggregation under physiological conditions","volume":"121","author":"Siffert","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2009.10.031_bib45","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3109\/08820539909069543","article-title":"Molecular mechanisms of vascular permeability in diabetic retinopathy","volume":"14","author":"Antonetti","year":"1999","journal-title":"Semin. Ophthalmol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X09019950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X09019950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T10:49:00Z","timestamp":1757760540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X09019950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0006291X09019950"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2009.10.031","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting carbonic anhydrase to treat diabetic retinopathy: Emerging evidences and encouraging results","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2009.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}